Paslick P. Martin 4
4 · HCA Healthcare, Inc. · Filed Apr 6, 2023
Insider Transaction Report
Form 4
Paslick P. Martin
SVP and CIO
Transactions
- Sale
Common Stock
2023-04-04$265.00/sh−3,034$804,010→ 24,643 total - Tax Payment
Common Stock
2023-04-05$271.31/sh−3,461$939,004→ 27,182 total - Exercise/Conversion
Stock Appreciation Right
2023-04-05−6,000→ 6,340 totalExercise: $81.96Exp: 2027-02-01→ Common Stock (6,000 underlying) - Exercise/Conversion
Common Stock
2023-04-05$81.96/sh+6,000$491,760→ 30,643 total
Holdings
- 60,000(indirect: By Trust)
Common Stock
- 3,000(indirect: By Trust)
Common Stock
- 63,999(indirect: By Trust)
Common Stock
Footnotes (2)
- [F1]The exercise of stock appreciation rights and sale of shares reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 10, 2022.
- [F2]The stock appreciation rights vested in four equal annual installments beginning on February 1, 2018.